Industry › Clinical Trials

Press Releases

Novotech 的灵活工作政策入围最佳工作场所灵活性计划“2022 年卓越奖”

Jul 25, 2022 21:00 HKT/SGT

Novotech 的靈活工作政策入圍最佳工作場所靈活性計劃“2022 年卓越獎”

Jul 25, 2022 21:00 HKT/SGT

Novotech's Flexible Work Policy is Finalist in Best Workplace Flexibility Program "Excellence Award 2022"

Jul 25, 2022 09:00 HKT/SGT

TrialWire Technology Platform Rolls Out World First SMS/Text Patient Contact System Across all Studies Globally

Jul 20, 2022 09:00 HKT/SGT

노보텍과 엔드포인트, “중국의 세포 및 유전자 치료의 진화: 범용성 CAR-T 사례”에 관해 발표

Jul 19, 2022 18:00 HKT/SGT

Therapeutic Goods Administration Grants Provisional Approval for Moderna's COVID-19 Vaccine in Children Aged Six Months to Five Years

Jul 19, 2022 11:00 HKT/SGT

Novotech和Endpoints展示“中国细胞和基因治疗的演变：通用CAR-T的案例”

Jul 19, 2022 07:00 HKT/SGT

Novotech和Endpoints展示“中國細胞和基因治療的演變：通用CAR-T的案例”

Jul 19, 2022 07:00 HKT/SGT

Novotech and Endpoints Present "Evolution of Cell & Gene Therapy in China: The Case for Universal CAR-T"

Jul 18, 2022 16:00 HKT/SGT

TrialWire(TM) 技术平台宣布基于成功的患者招募计划

Jul 18, 2022 15:00 HKT/SGT

TrialWire Technology Platform Announces Success-based Patient Recruitment Plan

Jul 18, 2022 15:00 HKT/SGT

TrialWire(TM) 技術平台宣布基於成功的患者招募計劃

Jul 18, 2022 15:00 HKT/SGT

노보텍 고객사 SK바이오사이언스, 스카이코비원(SKYCovione(TM)) 코로나19 백신 국내 승인

Jul 14, 2022 20:00 HKT/SGT

Novotech 客户 SK bioscience 在韩国获得 SKYCovione(TM) COVID-19 疫苗批准

Jul 14, 2022 08:00 HKT/SGT

Novotech 客戶 SK bioscience 在韓國獲得 SKYCovione(TM) COVID-19 疫苗批准

Jul 14, 2022 08:00 HKT/SGT

Novotech Client SK bioscience Achieves SKYCovione(TM) COVID-19 Vaccine Approval in Korea

Jul 13, 2022 14:30 HKT/SGT

노보텍, 2022 코리아 바이오프로세싱 엑설런스 어워드에서 ‘2022년 최고 바이오로직스 CRO 어워드’ 수상

Jun 29, 2022 19:00 HKT/SGT

Novotech在2022年韩国生物工艺卓越奖中获得“2022年最佳生物制剂CRO奖”

Jun 29, 2022 07:00 HKT/SGT

Novotech Receives "Best Biologics CRO Award 2022" at Korea Bioprocessing Excellence Awards 2022

Jun 29, 2022 07:00 HKT/SGT

Novotech在2022年韓國生物工藝卓越獎中獲得“2022年最佳生物製劑CRO獎”

Jun 29, 2022 07:00 HKT/SGT